Publisert 06.03.2019

Filing of additional Hong Kong patent application

The Patents registry of the Hong Kong Intellectual Property Department has verified receipt of Hong Kong Patent Application No. 16104205.5 from Regenics on January 25th 2019. The Hong Kong patent application is based on EP Patent Application No. 13844535.8

Title: USE OF CELLULAR EXTRACTS FOR SKIN REJUVENATION

The granting is expected within 5 months from the filing date.  The application has been assigned serial number 16104205.5.       

 

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.